Histological evaluation of the propagation of α-synuclein into grafted human induced pluripotent stem cell-derived neurons Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050
Clinical trials of cell transplantation therapy using fetal mesencephalic tissue provided a proof-of-concept for regenerative therapy for the patients with Parkinson's disease. Postmortem studies of the patients who received fetal grafts revealed that α-synuclein (α-syn)+ Lewy body-like inclusions were emerged in long-term transplantation and may reduce the clinical outcomes even the grafts were well survived in the recipients. Various studies were conducted to reveal that the host derived α-syn are transferred to the grafted neurons to assess the exsert of α-syn+ inclusions in the grafts. However, these studies remain the possibility to detect the intrinsic expression of α-syn in the grafted neurons. Here, we demonstrated that the human α-syn preformed fibrils inoculated into the cerebral cortex were transferred to SNCA-/- human induced pluripotent stem cell-derived midbrain dopaminergic (mDA) neurons grafted into the striatum of rats. Because grafted SNCA-/- hiPSC-derived mDA neurons lack the intrinsic expression of α-syn protein, the human α-syn-immunoreactivity found in the grafted cells should be derived from the host brain. Our results clearly showed that host-to-graft propagation of α-syn was occurred, and this work contributes to understand the molecular mechanisms to form the α-syn inclusions in the grafted mDA neurons.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050
- https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdf
- OA Status
- diamond
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390653368
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390653368Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050Digital Object Identifier
- Title
-
Histological evaluation of the propagation of α-synuclein into grafted human induced pluripotent stem cell-derived neuronsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-01-01Full publication date if available
- Authors
-
Kaneyasu Nishimura, Serina Gima, Takashi Ohgita, Hiroyuki Saito, Kazuyuki TakataList of authors in order
- Landing page
-
https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050Publisher landing page
- PDF URL
-
https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdfDirect OA link when available
- Concepts
-
Induced pluripotent stem cell, Transplantation, Striatum, Parkinson's disease, Biology, Substantia nigra, Dopaminergic, Pathology, Neuroscience, Human brain, Cell biology, Embryonic stem cell, Dopamine, Medicine, Disease, Internal medicine, Biochemistry, GeneTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390653368 |
|---|---|
| doi | https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050 |
| ids.doi | https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050 |
| ids.openalex | https://openalex.org/W4390653368 |
| fwci | 0.0 |
| type | article |
| title | Histological evaluation of the propagation of α-synuclein into grafted human induced pluripotent stem cell-derived neurons |
| biblio.issue | 0 |
| biblio.volume | 97 |
| biblio.last_page | B |
| biblio.first_page | 2 |
| topics[0].id | https://openalex.org/T10483 |
| topics[0].field.id | https://openalex.org/fields/28 |
| topics[0].field.display_name | Neuroscience |
| topics[0].score | 0.9973999857902527 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2804 |
| topics[0].subfield.display_name | Cellular and Molecular Neuroscience |
| topics[0].display_name | Nerve injury and regeneration |
| topics[1].id | https://openalex.org/T10085 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9962000250816345 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Parkinson's Disease Mechanisms and Treatments |
| topics[2].id | https://openalex.org/T10106 |
| topics[2].field.id | https://openalex.org/fields/28 |
| topics[2].field.display_name | Neuroscience |
| topics[2].score | 0.9839000105857849 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2805 |
| topics[2].subfield.display_name | Cognitive Neuroscience |
| topics[2].display_name | Autism Spectrum Disorder Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C107459253 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7318739891052246 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q674925 |
| concepts[0].display_name | Induced pluripotent stem cell |
| concepts[1].id | https://openalex.org/C2911091166 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6530661582946777 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q106419912 |
| concepts[1].display_name | Transplantation |
| concepts[2].id | https://openalex.org/C2780062018 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5972931981086731 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1319792 |
| concepts[2].display_name | Striatum |
| concepts[3].id | https://openalex.org/C2779734285 |
| concepts[3].level | 3 |
| concepts[3].score | 0.551565945148468 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11085 |
| concepts[3].display_name | Parkinson's disease |
| concepts[4].id | https://openalex.org/C86803240 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5395464301109314 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[4].display_name | Biology |
| concepts[5].id | https://openalex.org/C2780938664 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5072748064994812 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q753278 |
| concepts[5].display_name | Substantia nigra |
| concepts[6].id | https://openalex.org/C137183658 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4853162169456482 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q461076 |
| concepts[6].display_name | Dopaminergic |
| concepts[7].id | https://openalex.org/C142724271 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4692031741142273 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[7].display_name | Pathology |
| concepts[8].id | https://openalex.org/C169760540 |
| concepts[8].level | 1 |
| concepts[8].score | 0.46024981141090393 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[8].display_name | Neuroscience |
| concepts[9].id | https://openalex.org/C2777670902 |
| concepts[9].level | 2 |
| concepts[9].score | 0.45814061164855957 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q492038 |
| concepts[9].display_name | Human brain |
| concepts[10].id | https://openalex.org/C95444343 |
| concepts[10].level | 1 |
| concepts[10].score | 0.4450503885746002 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[10].display_name | Cell biology |
| concepts[11].id | https://openalex.org/C145103041 |
| concepts[11].level | 3 |
| concepts[11].score | 0.3837730288505554 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1151519 |
| concepts[11].display_name | Embryonic stem cell |
| concepts[12].id | https://openalex.org/C513476851 |
| concepts[12].level | 2 |
| concepts[12].score | 0.2543327808380127 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q170304 |
| concepts[12].display_name | Dopamine |
| concepts[13].id | https://openalex.org/C71924100 |
| concepts[13].level | 0 |
| concepts[13].score | 0.22606903314590454 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[13].display_name | Medicine |
| concepts[14].id | https://openalex.org/C2779134260 |
| concepts[14].level | 2 |
| concepts[14].score | 0.1853432059288025 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[14].display_name | Disease |
| concepts[15].id | https://openalex.org/C126322002 |
| concepts[15].level | 1 |
| concepts[15].score | 0.13378790020942688 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[15].display_name | Internal medicine |
| concepts[16].id | https://openalex.org/C55493867 |
| concepts[16].level | 1 |
| concepts[16].score | 0.09532323479652405 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[16].display_name | Biochemistry |
| concepts[17].id | https://openalex.org/C104317684 |
| concepts[17].level | 2 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[17].display_name | Gene |
| keywords[0].id | https://openalex.org/keywords/induced-pluripotent-stem-cell |
| keywords[0].score | 0.7318739891052246 |
| keywords[0].display_name | Induced pluripotent stem cell |
| keywords[1].id | https://openalex.org/keywords/transplantation |
| keywords[1].score | 0.6530661582946777 |
| keywords[1].display_name | Transplantation |
| keywords[2].id | https://openalex.org/keywords/striatum |
| keywords[2].score | 0.5972931981086731 |
| keywords[2].display_name | Striatum |
| keywords[3].id | https://openalex.org/keywords/parkinsons-disease |
| keywords[3].score | 0.551565945148468 |
| keywords[3].display_name | Parkinson's disease |
| keywords[4].id | https://openalex.org/keywords/biology |
| keywords[4].score | 0.5395464301109314 |
| keywords[4].display_name | Biology |
| keywords[5].id | https://openalex.org/keywords/substantia-nigra |
| keywords[5].score | 0.5072748064994812 |
| keywords[5].display_name | Substantia nigra |
| keywords[6].id | https://openalex.org/keywords/dopaminergic |
| keywords[6].score | 0.4853162169456482 |
| keywords[6].display_name | Dopaminergic |
| keywords[7].id | https://openalex.org/keywords/pathology |
| keywords[7].score | 0.4692031741142273 |
| keywords[7].display_name | Pathology |
| keywords[8].id | https://openalex.org/keywords/neuroscience |
| keywords[8].score | 0.46024981141090393 |
| keywords[8].display_name | Neuroscience |
| keywords[9].id | https://openalex.org/keywords/human-brain |
| keywords[9].score | 0.45814061164855957 |
| keywords[9].display_name | Human brain |
| keywords[10].id | https://openalex.org/keywords/cell-biology |
| keywords[10].score | 0.4450503885746002 |
| keywords[10].display_name | Cell biology |
| keywords[11].id | https://openalex.org/keywords/embryonic-stem-cell |
| keywords[11].score | 0.3837730288505554 |
| keywords[11].display_name | Embryonic stem cell |
| keywords[12].id | https://openalex.org/keywords/dopamine |
| keywords[12].score | 0.2543327808380127 |
| keywords[12].display_name | Dopamine |
| keywords[13].id | https://openalex.org/keywords/medicine |
| keywords[13].score | 0.22606903314590454 |
| keywords[13].display_name | Medicine |
| keywords[14].id | https://openalex.org/keywords/disease |
| keywords[14].score | 0.1853432059288025 |
| keywords[14].display_name | Disease |
| keywords[15].id | https://openalex.org/keywords/internal-medicine |
| keywords[15].score | 0.13378790020942688 |
| keywords[15].display_name | Internal medicine |
| keywords[16].id | https://openalex.org/keywords/biochemistry |
| keywords[16].score | 0.09532323479652405 |
| keywords[16].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1254/jpssuppl.97.0_2-b-p-050 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210239061 |
| locations[0].source.issn | 2435-4953 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2435-4953 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Proceedings for Annual Meeting of The Japanese Pharmacological Society |
| locations[0].source.host_organization | https://openalex.org/P4310313602 |
| locations[0].source.host_organization_name | Japanese Pharmacological Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310313602 |
| locations[0].source.host_organization_lineage_names | Japanese Pharmacological Society |
| locations[0].license | |
| locations[0].pdf_url | https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Proceedings for Annual Meeting of The Japanese Pharmacological Society |
| locations[0].landing_page_url | https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5103184289 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5582-3341 |
| authorships[0].author.display_name | Kaneyasu Nishimura |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I133984924 |
| authorships[0].affiliations[0].raw_affiliation_string | Lab. Func. Brain Construct. Doshisha Univ., |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I25998863 |
| authorships[0].affiliations[1].raw_affiliation_string | Joint Res. Lab., Kyoto Pharm. Univ., |
| authorships[0].institutions[0].id | https://openalex.org/I133984924 |
| authorships[0].institutions[0].ror | https://ror.org/01fxdkm29 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I133984924 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Doshisha University |
| authorships[0].institutions[1].id | https://openalex.org/I25998863 |
| authorships[0].institutions[1].ror | https://ror.org/01ytgve10 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I25998863 |
| authorships[0].institutions[1].country_code | JP |
| authorships[0].institutions[1].display_name | Kyoto Pharmaceutical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kaneyasu Nishimura |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Joint Res. Lab., Kyoto Pharm. Univ.,, Lab. Func. Brain Construct. Doshisha Univ., |
| authorships[1].author.id | https://openalex.org/A5052681981 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Serina Gima |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I25998863 |
| authorships[1].affiliations[0].raw_affiliation_string | Joint Res. Lab., Kyoto Pharm. Univ., |
| authorships[1].institutions[0].id | https://openalex.org/I25998863 |
| authorships[1].institutions[0].ror | https://ror.org/01ytgve10 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I25998863 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Kyoto Pharmaceutical University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Serina Gima |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Joint Res. Lab., Kyoto Pharm. Univ., |
| authorships[2].author.id | https://openalex.org/A5063121188 |
| authorships[2].author.orcid | https://orcid.org/0009-0002-2631-318X |
| authorships[2].author.display_name | Takashi Ohgita |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I25998863 |
| authorships[2].affiliations[0].raw_affiliation_string | Cent. Instru. Anal., Kyoto Pharm. Univ., |
| authorships[2].institutions[0].id | https://openalex.org/I25998863 |
| authorships[2].institutions[0].ror | https://ror.org/01ytgve10 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I25998863 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Kyoto Pharmaceutical University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Takashi Ohgita |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Cent. Instru. Anal., Kyoto Pharm. Univ., |
| authorships[3].author.id | https://openalex.org/A5000539432 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1497-1425 |
| authorships[3].author.display_name | Hiroyuki Saito |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I25998863 |
| authorships[3].affiliations[0].raw_affiliation_string | Dept. Biophys. Chem., Kyoto Pharm. Univ. |
| authorships[3].institutions[0].id | https://openalex.org/I25998863 |
| authorships[3].institutions[0].ror | https://ror.org/01ytgve10 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I25998863 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Kyoto Pharmaceutical University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hiroyuki Saito |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Dept. Biophys. Chem., Kyoto Pharm. Univ. |
| authorships[4].author.id | https://openalex.org/A5032064265 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5332-1279 |
| authorships[4].author.display_name | Kazuyuki Takata |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I25998863 |
| authorships[4].affiliations[0].raw_affiliation_string | Joint Res. Lab., Kyoto Pharm. Univ., |
| authorships[4].institutions[0].id | https://openalex.org/I25998863 |
| authorships[4].institutions[0].ror | https://ror.org/01ytgve10 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I25998863 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Kyoto Pharmaceutical University |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Kazuyuki Takata |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Joint Res. Lab., Kyoto Pharm. Univ., |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Histological evaluation of the propagation of α-synuclein into grafted human induced pluripotent stem cell-derived neurons |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10483 |
| primary_topic.field.id | https://openalex.org/fields/28 |
| primary_topic.field.display_name | Neuroscience |
| primary_topic.score | 0.9973999857902527 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2804 |
| primary_topic.subfield.display_name | Cellular and Molecular Neuroscience |
| primary_topic.display_name | Nerve injury and regeneration |
| related_works | https://openalex.org/W2913997818, https://openalex.org/W2380638043, https://openalex.org/W3216960204, https://openalex.org/W2028580402, https://openalex.org/W1596619396, https://openalex.org/W2371862965, https://openalex.org/W2027648752, https://openalex.org/W2372623231, https://openalex.org/W1974042971, https://openalex.org/W2419084773 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1254/jpssuppl.97.0_2-b-p-050 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210239061 |
| best_oa_location.source.issn | 2435-4953 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2435-4953 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Proceedings for Annual Meeting of The Japanese Pharmacological Society |
| best_oa_location.source.host_organization | https://openalex.org/P4310313602 |
| best_oa_location.source.host_organization_name | Japanese Pharmacological Society |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310313602 |
| best_oa_location.source.host_organization_lineage_names | Japanese Pharmacological Society |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Proceedings for Annual Meeting of The Japanese Pharmacological Society |
| best_oa_location.landing_page_url | https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050 |
| primary_location.id | doi:10.1254/jpssuppl.97.0_2-b-p-050 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210239061 |
| primary_location.source.issn | 2435-4953 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2435-4953 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Proceedings for Annual Meeting of The Japanese Pharmacological Society |
| primary_location.source.host_organization | https://openalex.org/P4310313602 |
| primary_location.source.host_organization_name | Japanese Pharmacological Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310313602 |
| primary_location.source.host_organization_lineage_names | Japanese Pharmacological Society |
| primary_location.license | |
| primary_location.pdf_url | https://www.jstage.jst.go.jp/article/jpssuppl/97/0/97_2-B-P-050/_pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Proceedings for Annual Meeting of The Japanese Pharmacological Society |
| primary_location.landing_page_url | https://doi.org/10.1254/jpssuppl.97.0_2-b-p-050 |
| publication_date | 2023-01-01 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 11 |
| abstract_inverted_index.be | 157 |
| abstract_inverted_index.in | 40, 55, 82, 98, 152, 188 |
| abstract_inverted_index.of | 2, 24, 79, 96, 133, 145, 170 |
| abstract_inverted_index.to | 62, 71, 75, 91, 118, 178, 183 |
| abstract_inverted_index.we | 103 |
| abstract_inverted_index.Our | 163 |
| abstract_inverted_index.and | 43, 174 |
| abstract_inverted_index.are | 69 |
| abstract_inverted_index.for | 13, 16 |
| abstract_inverted_index.mDA | 139, 191 |
| abstract_inverted_index.may | 44 |
| abstract_inverted_index.the | 17, 25, 46, 50, 56, 65, 72, 77, 83, 89, 93, 99, 106, 113, 131, 142, 148, 153, 160, 180, 185, 189 |
| abstract_inverted_index.was | 172 |
| abstract_inverted_index.who | 27 |
| abstract_inverted_index.Lewy | 35 |
| abstract_inverted_index.cell | 3 |
| abstract_inverted_index.even | 49 |
| abstract_inverted_index.form | 184 |
| abstract_inverted_index.from | 159 |
| abstract_inverted_index.host | 66, 161 |
| abstract_inverted_index.into | 112, 130 |
| abstract_inverted_index.lack | 141 |
| abstract_inverted_index.stem | 123 |
| abstract_inverted_index.that | 32, 64, 105, 167 |
| abstract_inverted_index.this | 175 |
| abstract_inverted_index.well | 53 |
| abstract_inverted_index.were | 38, 52, 60, 116 |
| abstract_inverted_index.with | 19 |
| abstract_inverted_index.work | 176 |
| abstract_inverted_index.(mDA) | 127 |
| abstract_inverted_index.Here, | 102 |
| abstract_inverted_index.cells | 155 |
| abstract_inverted_index.fetal | 7, 29 |
| abstract_inverted_index.found | 151 |
| abstract_inverted_index.human | 107, 120, 149 |
| abstract_inverted_index.rats. | 134 |
| abstract_inverted_index.these | 86 |
| abstract_inverted_index.using | 6 |
| abstract_inverted_index.assess | 76 |
| abstract_inverted_index.brain. | 162 |
| abstract_inverted_index.cortex | 115 |
| abstract_inverted_index.detect | 92 |
| abstract_inverted_index.exsert | 78 |
| abstract_inverted_index.grafts | 30, 51 |
| abstract_inverted_index.reduce | 45 |
| abstract_inverted_index.remain | 88 |
| abstract_inverted_index.reveal | 63 |
| abstract_inverted_index.should | 156 |
| abstract_inverted_index.showed | 166 |
| abstract_inverted_index.tissue | 9 |
| abstract_inverted_index.trials | 1 |
| abstract_inverted_index.α-syn | 68, 97, 108, 146, 171, 186 |
| abstract_inverted_index.Because | 135 |
| abstract_inverted_index.SNCA-/- | 119, 137 |
| abstract_inverted_index.Various | 58 |
| abstract_inverted_index.clearly | 165 |
| abstract_inverted_index.derived | 67, 158 |
| abstract_inverted_index.emerged | 39 |
| abstract_inverted_index.fibrils | 110 |
| abstract_inverted_index.grafted | 73, 100, 129, 136, 154, 190 |
| abstract_inverted_index.grafts. | 84 |
| abstract_inverted_index.induced | 121 |
| abstract_inverted_index.neurons | 74, 128, 140 |
| abstract_inverted_index.results | 164 |
| abstract_inverted_index.studies | 23, 59, 87 |
| abstract_inverted_index.therapy | 5, 15 |
| abstract_inverted_index.α-syn+ | 80 |
| abstract_inverted_index.Clinical | 0 |
| abstract_inverted_index.However, | 85 |
| abstract_inverted_index.cerebral | 114 |
| abstract_inverted_index.clinical | 47 |
| abstract_inverted_index.disease. | 21 |
| abstract_inverted_index.midbrain | 125 |
| abstract_inverted_index.neurons. | 101, 192 |
| abstract_inverted_index.outcomes | 48 |
| abstract_inverted_index.patients | 18, 26 |
| abstract_inverted_index.protein, | 147 |
| abstract_inverted_index.provided | 10 |
| abstract_inverted_index.received | 28 |
| abstract_inverted_index.revealed | 31 |
| abstract_inverted_index.striatum | 132 |
| abstract_inverted_index.survived | 54 |
| abstract_inverted_index.(α-syn)+ | 34 |
| abstract_inverted_index.body-like | 36 |
| abstract_inverted_index.conducted | 61 |
| abstract_inverted_index.intrinsic | 94, 143 |
| abstract_inverted_index.long-term | 41 |
| abstract_inverted_index.molecular | 181 |
| abstract_inverted_index.occurred, | 173 |
| abstract_inverted_index.preformed | 109 |
| abstract_inverted_index.Postmortem | 22 |
| abstract_inverted_index.expression | 95, 144 |
| abstract_inverted_index.inclusions | 37, 81, 187 |
| abstract_inverted_index.inoculated | 111 |
| abstract_inverted_index.mechanisms | 182 |
| abstract_inverted_index.understand | 179 |
| abstract_inverted_index.Parkinson's | 20 |
| abstract_inverted_index.contributes | 177 |
| abstract_inverted_index.pluripotent | 122 |
| abstract_inverted_index.possibility | 90 |
| abstract_inverted_index.propagation | 169 |
| abstract_inverted_index.recipients. | 57 |
| abstract_inverted_index.transferred | 70, 117 |
| abstract_inverted_index.cell-derived | 124 |
| abstract_inverted_index.demonstrated | 104 |
| abstract_inverted_index.dopaminergic | 126 |
| abstract_inverted_index.regenerative | 14 |
| abstract_inverted_index.α-synuclein | 33 |
| abstract_inverted_index.hiPSC-derived | 138 |
| abstract_inverted_index.host-to-graft | 168 |
| abstract_inverted_index.mesencephalic | 8 |
| abstract_inverted_index.transplantation | 4, 42 |
| abstract_inverted_index.proof-of-concept | 12 |
| abstract_inverted_index.α-syn-immunoreactivity | 150 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5600000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.27097786 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |